← Back to headlines
Guardian Pharmacy, Chemours Issue EBITDA Forecasts
Guardian Pharmacy Services and Chemours have released their financial forecasts for upcoming periods. Guardian Pharmacy Services projects adjusted EBITDA of $123M-$127M, while Chemours expects Q2 adjusted EBITDA of $220M-$250M.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
